Literature DB >> 27799857

Brand Spanking II: Attack of the Clones (or, The Phantom Menace).

Scott Mintzer.   

Abstract

Year:  2016        PMID： 27799857      PMCID： PMC5083050          DOI： 10.5698/1535-7511-16.5.310

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  6 in total

1.  Brand spanking? The presumptive risks of generic antiepileptic drugs.

Authors:  Scott Mintzer
Journal:  Epilepsy Curr       Date:  2011-03       Impact factor: 7.500

2.  Effectiveness of first antiepileptic drug.

Authors:  P Kwan; M J Brodie
Journal:  Epilepsia       Date:  2001-10       Impact factor: 5.864

3.  Generic-to-generic lamotrigine switches in people with epilepsy: the randomised controlled EQUIGEN trial.

Authors:  Michael D Privitera; Timothy E Welty; Barry E Gidal; Francisco J Diaz; Ron Krebill; Jerzy P Szaflarski; Barbara A Dworetzky; John R Pollard; Edmund J Elder; Wenlei Jiang; Xiaohui Jiang; Michel Berg
Journal:  Lancet Neurol       Date:  2016-02-12       Impact factor: 44.182

4.  Seizure recurrence and remission after switching antiepileptic drugs.

Authors:  Sophia Pan Wang; Scott Mintzer; Christopher T Skidmore; Tingting Zhan; Erika Stuckert; Maromi Nei; Michael R Sperling
Journal:  Epilepsia       Date:  2012-08-29       Impact factor: 5.864

5.  Generic lamotrigine versus brand-name Lamictal bioequivalence in patients with epilepsy: A field test of the FDA bioequivalence standard.

Authors:  Tricia Y Ting; Wenlei Jiang; Robert Lionberger; Jessica Wong; Jace W Jones; Maureen A Kane; Allan Krumholz; Robert Temple; James E Polli
Journal:  Epilepsia       Date:  2015-07-23       Impact factor: 5.864

6.  Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency.

Authors:  P B Pennell; L Peng; D J Newport; J C Ritchie; A Koganti; D K Holley; M Newman; Z N Stowe
Journal:  Neurology       Date:  2007-11-28       Impact factor: 9.910
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.